To examine the role of macrophages in pulmonary late-phase reaction (L
PR), macrophages were reduced in sensitized guinea pigs by an intraven
ous injection of liposome-encapsulated dichloromethylene diphosphonate
(Cl(2)MDP). Macrophage reduction was evaluated by bronchoalveolar lav
age (BAL) fluid analysis. In Cl(2)MDP liposome-treated animals, the nu
mber of macrophages in BAL fluid significantly decreased by 56% compar
ed with PBS liposome-treated animals (1.6+/-0.1 vs. 3.6+/-0.4x10(6) ce
lls, p <0.01). The number of neutrophils, eosinophils, or lymphocytes
in BAL fluid showed no significant changes in these two groups. Both P
BS and Cl(2)MDP liposome-treated sensitized guinea pigs were challenge
d with an inhalation of antigen, and respiratory resistance (Rrs) was
measured. PBS liposome-treated animals (control) exhibited both immedi
ate (IPR) and late (LPR) increases in Rrs. The maximal increases in Rr
s at IPR and LPR were 217+/-19 and 187+/-20% of baseline values, respe
ctively (n=9). On the other hand, Cl(2)MDP liposome-treated animals sh
owed an immediate increase in Rrs (IPR); however, the late increase in
Rrs (LPR) was significantly suppressed (p <0.05). The maximal increas
es in Rrs at IPR and LPR were 200+/-13 and 134+/-11% of baseline value
s, respectively (n=8). In Cl(2)MDP liposome-treated animals, the numbe
rs of macrophages and neutrophils in BAL fluid 4 hr after antigen chal
lenge decreased by 45% and 54%, respectively, compared with PBS liposo
me-treated animals (p <0.05). In Cl(2)MDP liposome-treated animals, ne
utrophil chemotactic activity in BAL fluid 4 hr after antigen challeng
e decreased by 59% compared with PBS liposome-treated animals (p <0.05
). These results suggest that macrophages play an important role in th
e development of pulmonary LPR through the induction of neutrophil acc
umulation in the airways.